Page 1

Global Fondaparinux Market Analysis And Segment Forecasts To 2024

Phone No.: +1 (214) 884-6817 sales@orbisresearch.com

Email id:


Global Fondaparinux Market Analysis And Segment Forecasts To 2024 The global fondaparinux market is expected to reach USD 686.3 million by 2024, according to a new report by Grand View Research, Inc. Fondaparinux is majorly used during knee and hip replacement surgeries. Arixtra, manufactured by GSK group of companies is the branded drug of Fondaparinux. The drug witnessed patent expiry in 2002. As the active molecule is highly complex to manufacture, it faced low generic competition until 2011. Generic manufacturer companies, such as Alchemia Ltd. and Apotex, Inc., received the Abbreviated New Drug Application approval in 2011 and instantly started the production of generic drugs. Browse the report: http://www.orbisresearch.com/reports/index/fondaparinux-market-analysisby-product-branded-generic-and-segment-forecasts-to-2024 Fondaparinux is used as an anticoagulant and shows improved survival compared with lowmolecular-weight heparin. It is used for the prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and is administered subcutaneously. Moreover, Fondaparinux lowers the risk of ischemic events. The increasing collaboration between the key players for acquiring the Intellectual Property Rights (IPRs) in order to manufacture the molecule through patented technology is expected to drive growth.

Phone No.: +1 (214) 884-6817

Email id: sales@orbisresearch.com


Global Fondaparinux Market Analysis And Segment Forecasts To 2024 North America held the largest market share of the global market in 2015. Key factors attributing to the dominance include constantly increasing geriatric population, rising prevalence of thrombosis, and the introduction of low-cost generics of Fondaparinux in the U.S. Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/106342 Moreover, the presence of local active pharmaceutical ingredients manufacturers and contract research organizations in China increased the number of foreign investments in the country. As a result, China is estimated to grow at CAGR of 21.2% till 2024 Major companies identified in the market include Dr. Reddy’s Laboratories, Inc., GSK group of companies, Mylan N.V., and Alchemia among others.

Phone No.: +1 (214) 884-6817

Email id: sales@orbisresearch.com


Global Fondaparinux Market Analysis And Segment Forecasts To 2024 About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817

Email id: sales@orbisresearch.com

Global fondaparinux market forecast 2024  

Global Fondaparinux Market 2024 Forecasts Research Report Now Available with OrbisResearch.com.

Read more
Read more
Similar to
Popular now
Just for you